{"title":"新发传染病灾害下医学肿瘤学的挑战与展望","authors":"Sachi Morita, Noritoshi Kobayashi, Junji Tsurutani, Haruko Daga, Emiko Ohki, Takami Kashiwada, Kentaro Kawakami, Yoshiko Kitagawa, Masaki Maruta, Yasuhiro Fujiwara, Hironobu Minami","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The Japanese Society of Medical Oncology has conducted a questionnaire survey of its members over a 4-year period from 2020 to 2023 as part of the\"Survey on the Impact of Anticancer Drug Therapy under the Spread of COVID-19 Infection\". By summarizing the results of the questionnaire survey and reviewing the changes in cancer treatment in the aftermath of the COVID-19, focusing on the results of the 2023 survey which was conducted after the disease became category V infectious disease. It became clear that the COVID-19 not only had an impact on medical professionals and treatment choices but also had a significant impact on end-of-life care. This work was supported by MHLW Special Research Program (Grant Number JPMH20CA2046) and MHLW Research on Emerging and Re-emerging Infectious Diseases and Immunization(Program Grant Number JPMH21HA2011, JPMH23HA2011 and JPMH24HA2015).</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":"52 8","pages":"573-576"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Challenges and Prospects for Medical Oncology under the Emerging Infectious Disease Disaster].\",\"authors\":\"Sachi Morita, Noritoshi Kobayashi, Junji Tsurutani, Haruko Daga, Emiko Ohki, Takami Kashiwada, Kentaro Kawakami, Yoshiko Kitagawa, Masaki Maruta, Yasuhiro Fujiwara, Hironobu Minami\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The Japanese Society of Medical Oncology has conducted a questionnaire survey of its members over a 4-year period from 2020 to 2023 as part of the\\\"Survey on the Impact of Anticancer Drug Therapy under the Spread of COVID-19 Infection\\\". By summarizing the results of the questionnaire survey and reviewing the changes in cancer treatment in the aftermath of the COVID-19, focusing on the results of the 2023 survey which was conducted after the disease became category V infectious disease. It became clear that the COVID-19 not only had an impact on medical professionals and treatment choices but also had a significant impact on end-of-life care. This work was supported by MHLW Special Research Program (Grant Number JPMH20CA2046) and MHLW Research on Emerging and Re-emerging Infectious Diseases and Immunization(Program Grant Number JPMH21HA2011, JPMH23HA2011 and JPMH24HA2015).</p>\",\"PeriodicalId\":35588,\"journal\":{\"name\":\"Japanese Journal of Cancer and Chemotherapy\",\"volume\":\"52 8\",\"pages\":\"573-576\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese Journal of Cancer and Chemotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
[Challenges and Prospects for Medical Oncology under the Emerging Infectious Disease Disaster].
The Japanese Society of Medical Oncology has conducted a questionnaire survey of its members over a 4-year period from 2020 to 2023 as part of the"Survey on the Impact of Anticancer Drug Therapy under the Spread of COVID-19 Infection". By summarizing the results of the questionnaire survey and reviewing the changes in cancer treatment in the aftermath of the COVID-19, focusing on the results of the 2023 survey which was conducted after the disease became category V infectious disease. It became clear that the COVID-19 not only had an impact on medical professionals and treatment choices but also had a significant impact on end-of-life care. This work was supported by MHLW Special Research Program (Grant Number JPMH20CA2046) and MHLW Research on Emerging and Re-emerging Infectious Diseases and Immunization(Program Grant Number JPMH21HA2011, JPMH23HA2011 and JPMH24HA2015).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
